SCHEMBL6814129

SCHEMBL6814129

O=[N+]([O-])c1c(-c2ccc(Cl)cc2Cl)ccnc1NCCCCC1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 5/20 0.38
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
MAPT P10636 3/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
ACP1 P24666 1/20 0.35
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
STK17A Q9UEE5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817813 0.97 PRKCQ (0.39) PRKCQPIK3CAPIK3CBPIK3CGMAPT
SCHEMBL6817921 0.86 MAPT (0.36) PRKCQMAPTMEN1KMT2ANPC1
SCHEMBL7065294 0.85 CRHR1 (0.46) PIK3CAPIK3CBPIK3CGSMN1; SMN2STK17A
SCHEMBL6817700 0.83 MAPT (0.35) MAPTKMT2AACP1NPC1RAB9A
SCHEMBL6819213 0.82 MEN1 (0.39) PIK3CAPIK3CBPIK3CGMAPTMEN1
SCHEMBL6821721 0.80 NPC1 (0.34) MAPTMEN1KMT2AACP1NPC1
SCHEMBL6818176 0.80 MAPT (0.33) PRKCQMAPTMEN1KMT2ANPC1
SCHEMBL6813930 0.80 SCN9A (0.37) MAPTMEN1KMT2ANPC1CYP1A2
SCHEMBL7031206 0.78 PIK3CA (0.39) PRKCQPIK3CAPIK3CBPIK3CGCYP2D6
SCHEMBL6817636 0.77 BRD4 (0.37) PRKCQMAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004031189-A1 PYRIDINO AND PYRIMIDINO PYRAZINONES FOR TREATMENT OF ANXIETY AND DEPRESSION BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2004-04-15 WO disclosed